Drug Side Effects
Search
Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]
Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]
was reported 104 times
These side effects are most commonly reported by patients taking drugs of the Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] class:
#
Drug class
Count
0
DRUG RESISTANCE
19
1
HEADACHE
14
2
NAUSEA
14
3
FATIGUE
12
4
DIARRHOEA
10
5
ACUTE KIDNEY INJURY
6
6
ALANINE AMINOTRANSFERASE INCREASED
6
7
DECREASED APPETITE
5
8
OFF LABEL USE
5
9
ABDOMINAL PAIN
4
10
DIZZINESS
4
11
DRUG INEFFECTIVE
4
12
SKIN LESION
4
13
VOMITING
4
14
ABDOMINAL DISCOMFORT
3
15
HEPATIC CYTOLYSIS
3
16
MONKEYPOX
3
17
PRURITUS
3
18
BACK PAIN
2
19
CD4 LYMPHOCYTES DECREASED
2
20
CHEST DISCOMFORT
2
21
CHILLS
2
22
CONDITION AGGRAVATED
2
23
DRUG INTERACTION
2
24
HYPERSENSITIVITY
2
25
INCORRECT PRODUCT ADMINISTRATION DURATION
2
26
NEUTROPENIA
2
27
NEUTROPHIL COUNT DECREASED
2
28
OSTEOMYELITIS
2
29
PAIN
2
30
PARAESTHESIA
2
31
RENAL FAILURE
2
32
SEPTIC SHOCK
2
33
SHOCK HAEMORRHAGIC
2
34
TRANSAMINASES INCREASED
2
35
TREATMENT FAILURE
2
36
URINARY RETENTION
2
37
ACUTE RESPIRATORY FAILURE
1
38
AGRANULOCYTOSIS
1
39
ANORECTAL DISCOMFORT
1
40
ASPARTATE AMINOTRANSFERASE INCREASED
1
41
BLOOD ALBUMIN DECREASED
1
42
BLOOD BICARBONATE INCREASED
1
43
BLOOD BILIRUBIN DECREASED
1
44
BLOOD CALCIUM DECREASED
1
45
BLOOD CREATININE INCREASED
1
46
BLOOD PRESSURE INCREASED
1
47
BRAIN FOG
1
48
BURNING SENSATION
1
49
CARDIO-RESPIRATORY ARREST
1
50
CONSTIPATION
1
51
CYTOMEGALOVIRUS VIRAEMIA
1
52
DEATH
1
53
DISEASE PROGRESSION
1
54
DISTURBANCE IN ATTENTION
1
55
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION
1
56
DRUG LEVEL FLUCTUATING
1
57
DRUG RESISTANCE MUTATION
1
58
DRY SKIN
1
59
DUODENAL ULCER HAEMORRHAGE
1
60
DYSPEPSIA
1
61
DYSPHAGIA
1
62
DYSURIA
1
63
EOSINOPHILIA
1
64
FUNGAEMIA
1
65
GASTROINTESTINAL HAEMORRHAGE
1
66
GASTROOESOPHAGEAL REFLUX DISEASE
1
67
GENERALISED TONIC-CLONIC SEIZURE
1
68
HAEMATOCHEZIA
1
69
HAEMATOCRIT DECREASED
1
70
HAEMOGLOBIN DECREASED
1
71
HALLUCINATION
1
72
HEPATIC ENZYME INCREASED
1
73
HEPATOCELLULAR INJURY
1
74
HYPERHIDROSIS
1
75
HYPERKALAEMIA
1
76
HYPERTRANSAMINASAEMIA
1
77
HYPOAESTHESIA
1
78
HYPOXIA
1
79
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME
1
80
INFUSION RELATED REACTION
1
81
INTENSIVE CARE UNIT ACQUIRED WEAKNESS
1
82
INTENTIONAL DOSE OMISSION
1
83
INTENTIONAL PRODUCT USE ISSUE
1
84
IRRITABILITY
1
85
JUGULAR VEIN THROMBOSIS
1
86
KLEBSIELLA BACTERAEMIA
1
87
LOWER GASTROINTESTINAL HAEMORRHAGE
1
88
LYMPHOCYTE COUNT DECREASED
1
89
MONOCYTE COUNT DECREASED
1
90
MONOCYTOSIS
1
91
MUSCULAR WEAKNESS
1
92
MYALGIA
1
93
MYELITIS TRANSVERSE
1
94
NIGHTMARE
1
95
NODULE
1
96
ONYCHOCLASIS
1
97
PALPITATIONS
1
98
PERITONSILLAR ABSCESS
1
99
PRESCRIBED OVERDOSE
1
100
PROCTALGIA
1
101
PROCTITIS
1
102
PRODUCT INEFFECTIVE FOR UNAPPROVED USE
1
103
PRODUCT PRESCRIBING ISSUE
1
104
PRODUCT USE ISSUE
1
105
PROTEIN ALBUMIN RATIO DECREASED
1
106
PSYCHOTIC DISORDER
1
107
RASH
1
108
RASH MORBILLIFORM
1
109
RECTAL HAEMORRHAGE
1
110
RED BLOOD CELL COUNT DECREASED
1
111
RESTLESS LEGS SYNDROME
1
112
SKIN ULCER
1
113
SLEEP DISORDER
1
114
SLEEP PARALYSIS
1
115
SOMNOLENCE
1
116
STEATORRHOEA
1
117
SUICIDAL IDEATION
1
118
SUPERINFECTION BACTERIAL
1
119
THROMBOCYTOPENIA
1
120
TREMOR
1
121
UNDERDOSE
1
122
URTICARIA
1
123
VACCINATION SITE INJURY
1
124
VISION BLURRED
1